Figure 1.The flowchart of this investigation. To integrate multiple datasets to explore the role of ICD in the TME of LUAD, and to construct a signature to predict the prognosis and immunotherapy of LUAD patients.
Figure 1 — The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy | Aging
